category,datetime,headline,id,image,related,source,summary,url
company,1768257676,44th Annual J.P. Morgan Healthcare Conference,138080078,https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png,MRNA,SeekingAlpha,"2026-01-12. The following slide deck was published by Moderna, Inc.",https://finnhub.io/api/news?id=e97883fdc6d50ec16cbc336709c9a39c66709721db538b99cbc01f36525a8b68
company,1768256761,"Moderna, Inc. (MRNA) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript",138079999,https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png,MRNA,SeekingAlpha,"Moderna, Inc. (MRNA) 44th Annual J.P.",https://finnhub.io/api/news?id=963943ed84c7e1327d337317ecd3c9d305a2ceca993d4caa9bdd78e1f3313598
company,1768251000,Sector Update: Health Care Stocks Mixed Late Afternoon,138083266,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,MRNA,Yahoo,"Health care stocks were mixed late Monday afternoon, with the NYSE Health Care Index up 0.1% and the",https://finnhub.io/api/news?id=fd5dc118c4b0d053ffd18ef054451f38454fbf354f52b37019a24cf16f0a5a96
company,1768235220,Why Moderna Stock Is Dropping After Good News,138076409,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,MRNA,Yahoo,"Moderna  offered investors a glimpse at its upcoming earnings report as it pre-announced revenue above the midpoint of its prior guidance range.  Presenting at the annual J.P. Morgan Healthcare Conference on Monday, Moderna said it expects 2025 revenue of roughly $1.9 billion, $100 million above the midpoint of the range communicated on the company’s third-quarter earnings call.  The company still expects revenue growth of up to 10% in 2026, and reiterated that it expects non-adjusted operating expenses to decline to $4.9 billion from a range of $5 billion to $5.2 billion in 2025.",https://finnhub.io/api/news?id=48c32fe82007daec1a2ffcfe3829d5a4b22d184d0dd335f747de2832aaaf4e2f
company,1768232736,"Moderna Sees 2025 Revenue Close to Outlook Range, Affirms Growth Target For This Year",138075423,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,MRNA,Yahoo,Moderna (MRNA) said Monday that it expects its 2025 revenue to come in close to the top end of its g,https://finnhub.io/api/news?id=edffa94d9a4e90efc2a302010bc6398398a92fbf9b00421956980abbd202bca0
company,1768227720,"These Stocks Are Today’s Movers: Capital One, Amex, Affirm, JPMorgan, Nvidia, Walmart, Moderna, Abercrombie, and More",138075164,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,MRNA,Yahoo,Capital One tumbles and American Express declines after President Donald Trump calls for a cap of 10% on credit-card interest rates.,https://finnhub.io/api/news?id=b67f8dfae014376f3610632b0af7ce81a8ef83fb74dd5a6de9e3ba8c57f8c954
company,1768225860,Moderna Stock Rises. Revenue in 2025 Will Be Higher Than Midpoint of Guidance.,138075167,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,MRNA,Yahoo,"Moderna  gave investors a glimpse at its upcoming earnings report on Monday as it pre-announced revenue above the midpoint of its prior guidance range.  Presenting at the J.P. Morgan healthcare conference on Monday,  Moderna  said it expects 2025 revenue of roughly $1.9 billion, $100 million above the midpoint of the range communicated on the company’s third-quarter earnings call.  For 2026, the company still expects revenue growth of up to 10%, and reiterated that it expects non-adjusted operating expenses to decline from $5 billion to $5.2 billion in 2025 to $4.9 billion in 2026.",https://finnhub.io/api/news?id=d7758a1d637272be03a1ae037a95bbfd3aa605adf157d70323076a5a7c11bebe
company,1768222800,Commonwealth Fusion Systems Names Stephane Bancel to Board of Directors,138071339,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,MRNA,Yahoo,"Commonwealth Fusion Systems (CFS), the largest and leading private fusion company, today announced that Stephane Bancel, the Chief Executive Officer of Moderna Inc. who led that company's successful development, production, scaling, and global adoption of the COVID-19 vaccine, has joined as an Independent Member of the Board of Directors.",https://finnhub.io/api/news?id=95f822cb870f8a61cb849a98bc47f80cd3606cac228e24b386f1caaeb400869f
company,1768219200,Moderna Provides Business and Pipeline Updates at 44th Annual J.P. Morgan Healthcare Conference,138071327,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,MRNA,Yahoo,"Expects 2025 revenue of approximately $1.9 billion (unaudited), $100 million above midpoint communicated on 3Q25 Earnings Call Improves 2025 expected GAAP operating expenses by $200 million since 3Q25 Earnings Call Increases 2025 projected year-end ...",https://finnhub.io/api/news?id=527cc655a715fa2f2b6acf64eefe3d67173bbfb4c02662638cb303fabf67c192
